跳至主要内容
临床试验/NCT05990673
NCT05990673尚未招募不适用

Determination of the 50% and 95% Effective Dose of Remimazolam for Intravenous Anesthesia Induction in Pediatric Patients

Zhihong LU0 个研究点目标入组 25 人开始时间: 2023年8月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
25
主要终点
half effective dosage

研究概览

简要总结

Remimazolam has demonstrated the potential as a valuable medication for procedural sedation and general anesthesia. However, the effective dosage of remimazolam in pediatric patients is still unknown.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Sequential
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • age from 3 to 12 years old
  • patients scheduled for surgery under general anesthesia

排除标准

  • American Society of Anesthesiologists status >=Ⅲ
  • Body mass index>=28kg/m2
  • patients who cannot cooperate with intravenous anesthesia induction
  • patients with risk of difficult airway
  • patients who are allergic to benzodiazepines
  • patients with delayed neurologic function

研究组 & 干预措施

remimazolam

Experimental

remimazolam is given for anesthesia induction

干预措施: Remimazolam (Drug)

结局指标

主要结局

half effective dosage

时间窗: from injection of remimazolam to loss of consciousness, at an average of 5 minutes

the dosage by which half of the patients will be sedated

次要结局

  • 95% effective dosage(from injection of remimazolam to loss of consciousness, at an average of 5 minutes)

研究者

发起方
Zhihong LU
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Zhihong LU

Associate professor

Air Force Military Medical University, China

相似试验

Dose of Remi in Children | 临床试验